![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
![Video: Marine Serre on Building an Independent Label [English]](https://r.fashionunited.com/LqmL4gcTYaW-0R1pmasQw2Q6yxCrLLvNKSMy3RmjiQg/resize:fit:1200:630:0/gravity:ce/quality:70/aHR0cHM6Ly9mYXNoaW9udW5pdGVkLmNvbS9pbWcvdXBsb2FkLzIwMjUvMDQvMDQvbWFyaW5lLXNlcnJlLW0tczI0LTAzMC16em01bWVqYi0yMDIzLTA4LTIwLXBkNnpmbzc4LTIwMjUtMDQtMDQuanBlZw.jpeg)
.jpg)
Roche's Genentech builds autoimmune Repertoire with deal worth up to $765M
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T cell-targeted medicines in the autoimmune disease space.
Roche’s Genentech has inked a deal with Repertoire Immune Medicines aimed at discovering and developing T cell-targeted medicines in the autoimmune disease space.
